Pirin Antikörper (AA 1-290)
Kurzübersicht für Pirin Antikörper (AA 1-290) (ABIN7163461)
Target
Alle Pirin (PIR) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-290
-
Kreuzreaktivität
- Human
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human Pirin protein (1-290AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- Pirin (PIR)
-
Andere Bezeichnung
- PIR
-
Hintergrund
-
Background: Transcriptional coregulator of NF-kappa-B which facilitates binding of NF-kappa-B proteins to target kappa-B genes in a redox-state-dependent manner. May be required for efficient terminal myeloid maturation of hematopoietic cells. Has quercetin 2,3-dioxygenase activity (in vitro).
Aliases: 3-dioxygenase PIR antibody, Iron binding nuclear protein antibody, Pir antibody, PIR_HUMAN antibody, Pirin antibody, Probable quercetin 2 antibody, probable quercetin 2,3-dioxygenase PIR antibody, Probable quercetinase antibody
-
UniProt
- O00625
Target
-